Amedica (AMDA) PT Trimmed, 'Buy' Maintained at Needham & Company
Tweet Send to a Friend
Needham & Company analyst Mike Matson adjusts his price target on Amedica Corporation (NASDAQ: AMDA) to $10.00 (from $11.00) after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE